Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program (Q28359547)

1

0 references

M N Gourevitch

2

0 references

C Trinh

3

0 references

N Salomon

4

0 references

L Horn

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

5

0 references

language of work or name

English

0 references

publication date

September 2001

0 references

published in

Journal of Urban Health

0 references

volume

78

0 references

issue

3

0 references

page(s)

550-67

0 references

1 reference

Rifampin-Induced Methadone Withdrawal

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Community-wide implementation of targeted testing for and treatment of latent tuberculosis infection

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Review of published cost-effectiveness studies on tuberculosis treatment programmes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, Thailand

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Tuberculosis in drug users

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Secular trends of tuberculosis in western Europe.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Implications of directly observed therapy in tuberculosis control measures among IDUs.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

The economic impact of tuberculosis in hospitals in New York City: a preliminary analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Directly observed therapy for tuberculosis: history of an idea

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Controlled chemoprophylaxis trials in tuberculosis. A general review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Risk factors for human immunodeficiency virus infection in intravenous drug users

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Prophylaxis and treatment of HIV-related tuberculosis

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Successful adherence to observed prophylaxis and treatment of tuberculosis among drug users in a methadone program.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Health-care expenditures for tuberculosis in the United States.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Tuberculosis prevention: cost-effectiveness analysis of isoniazid chemoprophylaxis

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

High Risk of Active Tuberculosis in HIV-Infected Drug Users With Cutaneous Anergy

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Drug Dependence, A Possible New Risk Factor for Tuberculosis Disease

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Tuberculosis screening and compliance with return for skin test reading among active drug users.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Reliability of anergy skin testing in persons with HIV infection. The pulmonary Complications of HIV Infection Study Group

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Help-seeking and referrals in a needle exchange: a comprehensive service to injecting drug users

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3455907

Hospitalization of homeless persons with tuberculosis in the United States

27 November 2018

1 reference

12 December 2020

Provision of influenza and pneumococcal vaccines to injection drug users at a syringe exchange

1 reference

12 December 2020

Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection

1 reference

12 December 2020

A controlled trial of community-wide isoniazid prophylaxis in Alaska

1 reference

12 December 2020

Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis

1 reference

12 December 2020

Tuberculosis prevention in drug-treatment centers and correctional facilities--selected U.S. sites, 1990-1991

1 reference

12 December 2020

Risk for Developing Tuberculosis among Anergic Patients Infected with HIV

1 reference

12 December 2020

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

1 reference

12 December 2020

A prospective study of the risk of tuberculosis among HIV-infected patients

1 reference

12 December 2020

The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis

1 reference

12 December 2020

Two-stage tuberculin skin testing in an HIV-infected population: a preliminary report

1 reference

12 December 2020

Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA)

1 reference

12 December 2020

Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group

1 reference

12 December 2020

Tuberculosis screening at a syringe exchange program

1 reference

12 December 2020

Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention

1 reference

12 December 2020

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

1 reference

12 December 2020

Organizational issues in conducting tuberculosis screening at a syringe exchange program

1 reference

12 December 2020

Preventive Therapy for Tuberculosis in HIV-Infected Persons Analysis of Policy Options Based on Tuberculin Status and CD4 + Cell Count

1 reference

12 December 2020

Criteria for assessing cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiologic Research Study Group

1 reference

12 December 2020

Syringe exchange in the United States, 1996: a national profile

1 reference

12 December 2020